These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 37381657)

  • 21. The societal economic burden of autosomal dominant polycystic kidney disease in the United States.
    Cloutier M; Manceur AM; Guerin A; Aigbogun MS; Oberdhan D; Gauthier-Loiselle M
    BMC Health Serv Res; 2020 Feb; 20(1):126. PubMed ID: 32070341
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The Economic Burden of Vision Loss and Blindness in the United States.
    Rein DB; Wittenborn JS; Zhang P; Sublett F; Lamuda PA; Lundeen EA; Saaddine J
    Ophthalmology; 2022 Apr; 129(4):369-378. PubMed ID: 34560128
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Direct and indirect costs of non-vertebral fracture patients with osteoporosis in the US.
    Pike C; Birnbaum HG; Schiller M; Sharma H; Burge R; Edgell ET
    Pharmacoeconomics; 2010; 28(5):395-409. PubMed ID: 20402541
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Costs of illness of multiple sclerosis in Sweden: a population-based register study of people of working age.
    Gyllensten H; Wiberg M; Alexanderson K; Norlund A; Friberg E; Hillert J; Ernstsson O; Tinghög P
    Eur J Health Econ; 2018 Apr; 19(3):435-446. PubMed ID: 28488184
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Social/economic costs and health-related quality of life in patients with epidermolysis bullosa in Europe.
    Angelis A; Kanavos P; López-Bastida J; Linertová R; Oliva-Moreno J; Serrano-Aguilar P; Posada-de-la-Paz M; Taruscio D; Schieppati A; Iskrov G; Brodszky V; von der Schulenburg JM; Chevreul K; Persson U; Fattore G;
    Eur J Health Econ; 2016 Apr; 17 Suppl 1(Suppl 1):31-42. PubMed ID: 27107597
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cancer-related costs should be allocated in a comparable way-benchmarking costs of cancer in Nordic countries 2012-2017.
    Torkki P; Leskelä RL; Bugge C; Torfadottir JE; Karjalainen S
    Acta Oncol; 2022 Oct; 61(10):1216-1222. PubMed ID: 36151990
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The Economic Burden of Adults with Major Depressive Disorder in the United States (2019).
    Greenberg P; Chitnis A; Louie D; Suthoff E; Chen SY; Maitland J; Gagnon-Sanschagrin P; Fournier AA; Kessler RC
    Adv Ther; 2023 Oct; 40(10):4460-4479. PubMed ID: 37518849
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Economic burden of bilateral neovascular age-related macular degeneration: multi-country observational study.
    Cruess AF; Zlateva G; Xu X; Soubrane G; Pauleikhoff D; Lotery A; Mones J; Buggage R; Schaefer C; Knight T; Goss TF
    Pharmacoeconomics; 2008; 26(1):57-73. PubMed ID: 18088159
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The economic burden of asthma and chronic obstructive pulmonary disease and the impact of poor inhalation technique with commonly prescribed dry powder inhalers in three European countries.
    Lewis A; Torvinen S; Dekhuijzen PN; Chrystyn H; Watson AT; Blackney M; Plich A
    BMC Health Serv Res; 2016 Jul; 16():251. PubMed ID: 27406133
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The Economic Burden of Posttraumatic Stress Disorder in the United States From a Societal Perspective.
    Davis LL; Schein J; Cloutier M; Gagnon-Sanschagrin P; Maitland J; Urganus A; Guerin A; Lefebvre P; Houle CR
    J Clin Psychiatry; 2022 Apr; 83(3):. PubMed ID: 35485933
    [No Abstract]   [Full Text] [Related]  

  • 31. Economic burden of COPD in a Swedish cohort: the ARCTIC study.
    Lisspers K; Larsson K; Johansson G; Janson C; Costa-Scharplatz M; Gruenberger JB; Uhde M; Jorgensen L; Gutzwiller FS; Ställberg B
    Int J Chron Obstruct Pulmon Dis; 2018; 13():275-285. PubMed ID: 29391785
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The societal cost of depression: evidence from 10,000 Swedish patients in psychiatric care.
    Ekman M; Granström O; Omérov S; Jacob J; Landén M
    J Affect Disord; 2013 Sep; 150(3):790-7. PubMed ID: 23611536
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Economic Burden of Rheumatoid Arthritis in Italy: Possible Consequences on Anti-Citrullinated Protein Antibody-Positive Patients.
    Mennini FS; Marcellusi A; Gitto L; Iannone F
    Clin Drug Investig; 2017 Apr; 37(4):375-386. PubMed ID: 28074337
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Economic burden of hospital malnutrition: A cost-of-illness model.
    Inciong JFB; Chaudhary A; Hsu HS; Joshi R; Seo JM; Trung LV; Ungpinitpong W; Usman N; Pradelli L; Omaralsaleh AJ
    Clin Nutr ESPEN; 2022 Apr; 48():342-350. PubMed ID: 35331511
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Economic burden of attention-deficit/hyperactivity disorder among children and adolescents in the United States: a societal perspective.
    Schein J; Adler LA; Childress A; Cloutier M; Gagnon-Sanschagrin P; Davidson M; Kinkead F; Guerin A; Lefebvre P
    J Med Econ; 2022; 25(1):193-205. PubMed ID: 35068300
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The healthcare costs of treating human papillomavirus-related cancers in Norway.
    Hylin H; Thrane H; Pedersen K; Kristiansen IS; Burger EA
    BMC Cancer; 2019 May; 19(1):426. PubMed ID: 31064346
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Burden of illness of chronic low back pain in Sweden: a cross-sectional, retrospective study in primary care setting.
    Ekman M; Jönhagen S; Hunsche E; Jönsson L
    Spine (Phila Pa 1976); 2005 Aug; 30(15):1777-85. PubMed ID: 16094281
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Health Economic Consequences Associated With COVID-19-Related Delay in Melanoma Diagnosis in Europe.
    Maul LV; Jamiolkowski D; Lapides RA; Mueller AM; Hauschild A; Garbe C; Lorigan P; Gershenwald JE; Ascierto PA; Long GV; Wang-Evers M; Scolyer RA; Saravi B; Augustin M; Navarini AA; Legge S; Németh IB; Jánosi ÁJ; Mocellin S; Feller A; Manstein D; Zink A; Maul JT; Buja A; Adhikari K; Roider E
    JAMA Netw Open; 2024 Feb; 7(2):e2356479. PubMed ID: 38363565
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Economic impact of adverse drug events--a retrospective population-based cohort study of 4970 adults.
    Gyllensten H; Hakkarainen KM; Hägg S; Carlsten A; Petzold M; Rehnberg C; Jönsson AK
    PLoS One; 2014; 9(3):e92061. PubMed ID: 24637879
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Excess costs of multiple sclerosis: a register-based study in Sweden.
    Murley C; Tinghög P; Teni FS; Machado A; Alexanderson K; Hillert J; Karampampa K; Friberg E
    Eur J Health Econ; 2023 Nov; 24(8):1357-1371. PubMed ID: 36418785
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.